360 ONE Q1: consolidated PAT +16% to ₹331 Cr, but NPM slips to 26% as costs outpace revenue
PAT +16.1% YoY · revenue +26.9% · margins compressing · inline vs street
₹1,226.09 Cr
+26.9% YoY
₹330.53 Cr
+16.1% YoY
25.96%
-3.1pp YoY
₹8.13
360 ONE WAM reported consolidated PAT of ₹330.5 Cr for Q1 FY27, up 16.1% YoY (14.5% QoQ), on total income of ₹1,273.1 Cr (+29.9% YoY) and revenue from operations of ₹1,226.1 Cr (+26.9% YoY); basic EPS was ₹8.13. The print was broadly in line with street — consensus pointed to PAT ~₹330 Cr and EPS ~₹8.0 — and delivered no upside surprise, with the stock slipping ~1.6% post-results. (Management's own Results Update headlines a netted 'Total Revenue' of ₹870 Cr, +20%, and revenue from operations ₹822 Cr, +24.2%, on a presentation that differs from the statutory statement.)
Q1 FY-2027 vs prior quarters
The nuance sits below the topline: profit grew slower than revenue, so net profit margin compressed to ~26.0% from 29.1% a year ago (though it recovered from 24.7% in Q4). PBT rose only 13.3% YoY against total income up ~30%, as total expenses jumped ~40% YoY. The two squeeze points are finance costs of ₹354.0 Cr (+55% YoY), reflecting the growing NBFC/lending book, and employee costs of ₹326.0 Cr (+32% YoY). On management's own cost-to-income measure the ratio improved sequentially to 51.3% from 53.5%, keeping the Q4 FY27 target of ~49-49.5% in play, but on a clean YoY basis margins are still contracting.
The stock went into the print at ₹1,114.75, down 2.7% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.
Management provided a positive outlook for FY27, expecting continued growth driven by the wealth business, with ARR AUM growth projected at 12-15% and net flows robust. The company anticipates a gradual improvement in the cost-to-income ratio, aiming for a 100-150 basis point reduction from current levels by Q4 FY27, a
— This quarter: beat
The franchise metrics remain strong and confirm the bullish concall tone: overall AUM stood at ₹7,76,755 Cr, ARR AUM rose 19% YoY to ₹3,42,035 Cr — ahead of the 12-15% growth management had guided — and ARR net flows were a robust ₹10,815 Cr for the quarter. Wealth Management ARR AUM grew 24.2% YoY (Asset Management +8.2%), tangible net worth was ₹6,882 Cr and tangible RoE 19.4%. Alongside the results the Board declared an interim dividend of ₹6/share (₹243.78 Cr) and approved a 2026 ESAR scheme (up to 11.2 lakh rights). A contingent income-tax demand of ₹336.1 Cr arising from a search operation was disclosed but not provided for.
W1
Cost-to-income ratio: 51.3% in Q1 vs management's ~49-49.5% Q4 FY27 target — margin must catch up to AUM growth (NPM compressed to 26% YoY)
W2
Finance costs ₹354 Cr (+55% YoY): pace of NBFC/lending-book leverage and its drag on consolidated margin into H2
W3
ARR flow momentum after ₹10,815 Cr this quarter and ARR AUM +19% — sustaining the 12-15%+ growth guidance
Clean digital PDF, Limited Review (unaudited). No exceptional items in P&L. Standalone is a holdco: PAT fell YoY (₹83.5 Cr vs ₹112.1 Cr) purely on lower subsidiary dividend income (₹77.5 Cr vs ₹150.9 Cr) — not indicative; consolidated is the story. Contingent liability: income-tax demand ₹336.14 Cr (consol) / ₹192.42 Cr (standalone) from a Sec-132 search, appealed, not provided. Statutory prior-year (Jun-25) revenue from ops in the filing is ₹966.58 Cr (post-regroup) vs ₹911.46 Cr held in our DB; YoY computed on the filing's own comparative for consistency. Management's Results Update uses a netted presentation (Total Revenue ₹870 Cr, PAT ₹330 Cr) that differs from the statutory statement extracted here.
The ₹356 Crore Revenue Question
AUM growth beat and margins shine, but management disclosed only 71% of actual revenue on the call. The gap raises credibility questions even as the fundamentals remain solid.
360 One's Q1 looks like a clean beat: ARR AUM grew 19%, cost-to-income compressed 220 basis points, and net profit of ₹330.5 crore hit 26% of revenues. The market agreed, pushing the stock +2.44% on day 1. But the call transcript tells a different story. Management walked through ₹870 crore in revenue (ARR ₹614 crore + TBR ₹208 crore) while the actual filed result shows ₹1,226.1 crore—a ₹356 crore gap, or 41% of the number they didn't detail. That mismatch is the Q1 story.
₹870 Cr
ARR + TBR only
₹1,226 Cr
+34.5% YoY
₹356 Cr
29% of total revenue
What management claimed vs. what holds up
ARR AUM growth 12–15% FY27 guidance → Delivered 19% YoY; Wealth +24.2%, AM +8.2%
Cost-to-income improving 100–150 bps by Q4 → Q1 at 51.3% vs Q4 prior 53.5%; 220 bps QoQ on track
HNI break-even by end of FY27 → AUM ₹5.1k Cr, trail revenue ₹7–8 Cr started accruing; supported
ET Money restructured, break-even by year-end → Run-rate loss ₹3–3.5 Cr (vs ₹7 Cr prior); on trajectory
Total revenue ₹870 Cr, up 20% YoY → Delivered ₹1,226.1 Cr, up 34.5%; 41% gap unexplained
PAT growth 14.8% YoY → Delivered 16.1%; 130 bps understated
Where the missing ₹356 crore likely comes from
Management itemized ARR (wealth and asset management recurring fees, ₹614 Cr) and TBR (transaction-based: equity brokerage, private credit mandates, advisory; ₹208 Cr). The undisclosed ₹356 Cr likely spans three buckets. First, carry on alternates AUM. The call noted alternates AUM at ₹58–60k crore and carry yields 4 basis points (guideline 3–5 bps range), implying ₹240 crore annually or roughly ₹60 crore per quarter—a material line item absent from the call summary. Second, advisory and lending income on UHNI and HNI mandates, which typically show up in fee income, not ARR or TBR. Third, other income or exceptional items not reconciled on the call. Management's silence on these sources is not inherently misleading—many firms separate carry, advisory, and other income from core operating revenue—but the 41% variance between what was discussed and what was delivered signals selective communication.
The margin story: where credibility is earned
This is where 360 One shines and where the disclosure gap matters less. Reported margins are exceptional: NPM of 26% and OPM of 63% place the firm at a premium tier in wealth management globally. Cost-to-income of 51.3%, down 220 basis points from Q4's 53.5%, confirms the path to 49–50% by Q4 FY27 is real, not aspirational. The trajectory is driven by two levers: HNI scaling (₹5.1k crore AUM, 60+ RMs, trail revenue now accruing ₹7–8 crore) and ET Money restructuring (run-rate loss down from ₹7 crore to ₹3–3.5 crore per quarter). Both are visible in the numbers, tracked quarterly, and measurable. If these two businesses reach break-even direct cost by year-end as promised, the company can credibly guide to 49–50% cost-to-income full-year and 47–49% in the medium term (UHNI structurally operates at 45–47%).
The AUM story is genuinely strong
ARR AUM of ₹3.42 lakh crore grew 19% year-on-year, beating the prior 12–15% guidance by 400–700 basis points. Wealth AUM (the core business) grew 24.2% to ₹2.42 lakh crore on net flows of ₹13,379 crore, up sharply from ₹6,957 crore in Q4. This momentum is real: it reflects onboarded teams (B&K acquisition and recent hires) binding, organic wallet share expansion (clients >₹10 crore nearly doubled from 1,800–2,000 to 4,000 in 36 months), and HNI business migrating from nascent (₹600 crore in FY26) to material (₹5.1k crore in Q1 FY27). Asset Management AUM grew 8.2%, muted by one large institutional mandate reduction ($550–600 million → $175–180 million), a headwind management attributed to FII allocation tepidness and flagged as a one-off.
Retention pressure is real but contained
Retention fell from 78 basis points to 73–74 basis points quarter-on-quarter. Management unpacked this: 2–2.5 bps came from carry recognition (alternates outperformance rolling into total return and compressing yield), 2 bps from mix shift (advisory growing faster than distribution, reducing blended retention), and the balance from listed equity business compression. Crucially, management showed no underlying margin compression per business line. Advisory holds 30–35 bps, discretionary 40–45 bps, and distribution 65–70 bps—all stable. Only the listed equity segment (8–9% of revenue) showed pressure, a known secular headwind as clients migrate to alternatives and advisory-led mandates. This is not a structural profitability crisis; it's a product mix shift. If HNI and alternates (higher-retention buckets) scale as planned, blended retention can stabilize or inflect upward.
How the street is reading it
The stock rose 2.44% on day 1 (from ₹1,083.35 pre-result close), a measured pop reflecting a beat but not a surprise. Price has since held near day-1 levels (₹1,114.75), trading above the 20-day, 50-day, and 200-day moving averages (all clustered around ₹1,102). RSI sits at 58.6 (neutral), and volume has been declining—a sign that the rally lacks institutional thrust. More telling: FII ownership has compressed from 68.54% in Q1 FY26 to 63.33% now (down 2.19 percentage points quarter-on-quarter), while DII ownership has ticked up from 7.87% to 12.86%. The stock is down 9.78% from its all-time high but up 23% from its 52-week low, placing it mid-range in its annual envelope. The FII exit is the real story here. Management cited muted FII flows for 6–9 months and one institutional outflow, but the ownership data shows this is not a blip—foreign institutions have been systematically trimming since Q1 FY26. If macro headwinds persist (elevated rates, geopolitical uncertainty, India flows to US markets), FII outflows could accelerate, capping the stock's upside near-term even as the business delivers.
What changed this quarter
AUM growth beat confirmed: 19% YoY vs 12–15% prior guidance. Wealth +24.2% driven by onboarded teams and organic wallet expansion.
Cost-to-income trajectory reaffirmed: Q1 at 51.3% (vs Q4 53.5%); path to 49–50% by Q4 via HNI/ET Money profitability is on track.
HNI profitability path clarified: AUM scaled ₹5.1k crore; trail revenue now accruing ₹7–8 crore/qtr; expected to break even on direct cost by end-FY27.
UBS collaboration emerges as new catalyst: Target $500–600 million AUM exchange; fund launches and cross-referrals expected Q2+ FY27. Early-stage; unit economics deferred to 6-month review.
Retention pressure persists but de-risked: Fell 78→73–74 bps; management decomposed it (2–2.5 bps carry, 2 bps mix, residual listed equity). Underlying margins stable; no structural issue.
Revenue disclosure gap emerged: Call emphasized ₹870 Cr (ARR+TBR); delivered ₹1,226 Cr. 41% gap raises transparency questions on carry, advisory, other income.
The bull-bear ledger
AUM growth 19% YoY beats 12–15% guidance; wealth momentum real
Cost-to-income 220 bps improvement QoQ; trajectory to 49–50% believable
HNI profitability path clear; ₹5.1k Cr AUM, trail revenue accruing
Premium margins (26% NPM, 63% OPM) reflect pricing power and scale
Tangible ROE 19.4%; expected to improve as HNI/lending scale
Revenue disclosure gap ₹356 Cr (41%) unexplained; transparency concern
FII ownership down 2.19pp QoQ (68.54%→63.33% since Q1 FY26); systematic exit
One institutional mandate halved ($550M→$175M); concentration risk
Retention under pressure (78→73–74 bps); listed equity headwind persistent
UBS collaboration early-stage; $500–600M AUM target conservative, timeline uncertain
Cost-to-income improvement dependent on HNI/ET Money execution; if targets slip, could stall at 50–51%
Risks, ranked by how much they should concern a holder
Revenue recognition gap (₹356 Cr / 41%)
HighUndisclosed revenue streams (carry, advisory, other) inflate delivered vs disclosed numbers. Raises questions on management transparency and sustainability of reported margins if carry or other income is lumpy or cyclical.
FII flows negative; ownership down 2.19pp QoQ
HighInstitutions systematically trimmed from 68.54% (Q1 FY26) to 63.33% now. If macro headwinds persist (rates, geopolitics), FII outflows could accelerate, capping stock upside and creating valuation pressure.
Cost-to-income improvement dependent on HNI/ET Money execution
MediumGuidance of 49–50% by Q4 FY27 hinges on two businesses reaching profitability. If onboarding slows, churn accelerates, or losses persist longer, cost-to-income could stall at 50–51%, missing targets.
Retention pressure in listed equity (8–9% of revenue)
MediumPure product business (listed equity, discretionary) facing commoditization. If segment shrinks below 5%, revenue mix shift could cap overall retention at 70–72 bps long-term, pressuring margins.
UBS collaboration unproven; early-stage
MediumTarget $500–600M AUM conservative; timeline for profitability deferred. If integration underperforms or costs overrun, medium-term growth assumptions at risk.
What to watch next
1 · Revenue reconciliation
Management must itemize the ₹356 Cr revenue gap in next call or investor communication. Is it carry (alternates ₹60k Cr AUM × 4 bps ≈ ₹240 Cr/yr), advisory, lending, or exceptional? Credibility depends on clarity.
2 · HNI profitability milestone
Q2–Q4 progress toward break-even on direct cost. Trail revenue ₹7–8 Cr started accruing; migration of 4k underserviced <₹10 Cr clients expected next 3 months. Confirm this inflects profitability by Q4.
3 · Cost-to-income execution
Quarterly tracking toward 49–50% by Q4 FY27. If Q2–Q3 ratios stall above 51%, or either HNI/ET Money underperforms, the full-year target is at risk. This is the master metric.
4 · FII/DII ownership flows
Are DII additions sustainable as FII exits? If foreign institutions continue trimming and domestic buyers don't offset, ownership composition will shift materially, affecting valuation multiple and stock resilience in downturns.
5 · UBS fund launches and cross-referral traction
Q2+ FY27 milestones: fund launches, early AUM transfers, conversion rates. Early wins will validate the medium-term partnership upside and justify management's $500–600M target.
The debate
The single number to track from here
Cost-to-income at year-end Q4 FY27. If it lands at 49–50% as guided (driven by HNI/ET Money profitability), the business model inflects to a higher return-on-capital tier and multiple expansion is justified. If it stalls at 50–51%, the margin story falters and momentum slows. Every 25 basis points of miss costs roughly ₹80–100 crore in annual operating profit at this scale. That's the game.
360 One delivered a solid quarter—AUM growth beat, margins premium, cost trajectory confirmed. But the revenue disclosure gap and FII exit remind us that credibility in finance is earned quarterly and lost overnight. Management has executed on the hard operational metrics (AUM, cost-to-income, HNI scaling), but transparency on revenue sources and institutional flows will determine whether the stock re-rates higher or consolidates. The fundamentals are intact; the risk is on the narrative. Watch the Q2 call for a reconciliation of the ₹356 crore gap and clearer itemization of carry, advisory, and other income. Until then, the debate remains cautiously optimistic but unsettled.
Strong execution masks revenue disclosure gap; medium-term catalysts intact
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit AUM growth guidance (19% vs 12-15%); cost-to-income trajectory on track. Revenue/PAT growth rates understated in presentation vs delivered; transparency gap on revenue sources.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong margin delivery (26% NPM, 63% OPM) and AUM growth beat guidance. However, ₹370 Cr revenue gap between disclosed (₹870 Cr) and delivered (₹1,226 Cr) and 130 bps PAT growth discrepancy signal incomplete management communication. Near-term: solid execution but selective disclosure raises transparency concerns. Medium-term: HNI, ET Money break-even path, and UBS upside intact but early-stage.
₹870 Cr
Revenue · +20% YoY₹330.5 Cr
Reported PAT · +14.8% YoYExpanding
Margins · vs guidance: OverstatedDid the claims hold up?
ARR AUM growth 12-15% guidance for FY27
METDelivered 19% YoY; Wealth +24.2%, AM +8.2%
Cost-to-income improving toward 49-49.5% by Q4
METQ1 at 51.3% vs Q4 prev 53.5%; 220 bps QoQ improvement on track
Total revenue ₹870 Cr, up 20% YoY
MISSDelivered result shows ₹1,226.1 Cr revenue; 41% gap suggests incomplete disclosure or other revenue streams
PAT up 14.8% in quarter
OVERSTATEDDelivered YoY PAT growth 16.1%; 130 bps discrepancy vs stated
HNI break-even by end of FY27
METExpected to break even on direct cost end of year; trail revenue ₹7-8 Cr started accruing
ET Money restructured, expected break-even by end of year
METRun rate quarterly loss ₹3-3.5 Cr; prior ₹7 Cr; trajectory supports claim
Earnings quality
What changed since the last call
AUM growth guidance beat
UpgradeDelivered 19% YoY vs 12-15% prior guidance. Wealth +24.2% (₹13.4k Cr net flows) vs ₹7k Cr Q4; recent team onboardings driving.
Cost-to-income trajectory confirmed
NeutralQ1 at 51.3% vs Q4 53.5%; management reaffirms 49-49.5% by Q4 FY27 via HNI/ET Money break-even. 100-150 bps improvement guidance remains on track.
HNI profitability outlook improved
UpgradeExpected break-even on direct cost by end of FY27 (prior guidance was ambiguous). AUM scaled ₹5.1 Cr; 60+ RMs; trail revenue now accruing ₹7-8 Cr/qtr.
UBS collaboration early-stage
NewTarget $500-600M AUM exchange; funds launch and referrals expected Q2+ FY27. Unit economics deferred; management cautious on near-term P&L impact.
Retention pressure persistent
NeutralDeclined from 78 to 73-74 bps. Carry impact ₹2-2.5 bps; mix shift 2 bps. Listed equity business (8-9% of revenue) showing margin compression; offset by UHNI/advisory strength.
The Q&A
Moderate analyst pressure; management handled with specificity. Analysts pushed on net flows mix (wealth vs AMC), cost-to-income timing, retention drivers, UBS unit economics. Management acknowledged FII headwinds and one institutional outflow (₹375-425M) but defended flow trajectory. Tone grew slightly defensive on CEO continuity rumour (answered 125+ times); otherwise candid.
Net flows guidance mix — Mohit Mangal
AnsweredYes, 12-15% target still valid; 70:30 wealth-to-AMC split expected. PMS challenged structurally; shifting to AIF/MF/SIF. One large institutional mandate partial redemption was anomaly.
Cost-to-income decline — Mohit Mangal
AnsweredYes, 100-150 bps improvement expected to 49-49.5% by Q4 via HNI/ET Money break-even and operating leverage. Provided detailed phasing: HNI profitable this year; ET Money ₹3-3.5 Cr run-rate loss vs ₹7 Cr prior.
Private credit positioning — Mohit Mangal
AnsweredNascent industry (9-20% yield buckets). Operating 10-11% and 13-15% buckets with negligible defaults 7-8 years. No semi-liquid funds in India (regulatory discipline). Institutional demand from insurers. Industry growth potential comparable to private equity long-term.
Retention pressure factors — Prayesh Jain
AnsweredLargely carry recognition (2-2.5 bps) and mix shift (2 bps). No underlying margin compression per business line. Advisory 30-35 bps, discretionary 40-45 bps, distribution 65-70 bps unchanged. Only listed equity (8-9% revenue) showing pressure.
UBS operating leverage — Prayesh Jain
PartialMutually accretive at scale; no disproportionate cost add. Unit economics, retention, and pricing to be discovered over 6 months. Target $500-600M AUM; first step fund launches and cross-referrals next quarter.
RM count and long-term cost-to-income — Prayesh Jain
AnsweredStable UHNI cost-to-income 45-47% structurally (accounting for 100-200 bps hiring buffer). Bridge from 50-51% to 47% not coming from UHNI hiring but HNI/ET Money profitability. UHNI perpetual hiring curve offset by productivity gains.
Yield on new inflows — Aejas Lakhani
AnsweredAdvisory 30-35 bps; discretionary 45-50 bps; distribution 60-70 bps. Relationship ramp (competitive pressure eases as depth grows) drives upside as cross-platform usage increases.
Flow quality and wallet consolidation — Dipanjan Ghosh
AnsweredBiggest momentum at unit level (client count). Clients >₹10 Cr: grew 1,800-2,000 → 4,000 in 36 months (biggest opportunity). Current growth mix: new clients, higher wallet share at liquidity events, deeper cross-sell.
Core TBR and large transactions pipeline — Dipanjan Ghosh
AnsweredShifting from lumpy to recurring. Co-investment regs enable AI-PMS vehicles for long-term capital vs syndication. Structurally fewer large one-off TBR deals ahead. Equity brokerage now ₹75 Cr/qtr (stable, 10-15% upside). Target ₹125-150 Cr TBR/qtr with 10-15% organic growth.
Exceptional costs in P&L — Dipanjan Ghosh
AnsweredESOP and acquisition costs from B&K deal, non-recurring. Not on constant basis.
Carry yield stabilization — Dipanjan Ghosh
Partial4 bps is right level to model. Alternates AUM ₹58-60k Cr × 4 bps = ₹240 Cr/year. Range 3-5 bps realistic. This quarter at guidance level.
HNI growth trajectory — Siddharth
AnsweredHNI AUM ₹600 Cr (FY26) → ₹4k Cr (end FY26) → ₹5.1k Cr (Q1 FY27). 60+ RMs; 800+ clients; 90 bps retention. Trail revenue ₹7-8 Cr started Q1. Expect platform to stabilize; migration of 4k underserviced sub-10-Cr clients next 3 months. Will show profitability this year.
ECM mandate build-out — Siddharth
AnsweredEarly days; 6-person team (4 coverage + 2 compliance/process). Full strength by Oct-Dec 2026. Active pitching Jan 2027+. Current TBR <₹8 Cr/qtr. 2-3 year horizon: ECM could contribute 15-20% of ₹750-1000 Cr TBR revenue.
B&K acquisition synergies — Siddharth
AnsweredBiggest: equity brokerage ₹250-260 Cr (combined) → ₹310-320 Cr in Q1. Target 15-20% annual growth next 2-3 years via wealth-B&K research cross-sell. UHNI-ECM-research linkage opening wealth cross-sell to 600+ corporate treasuries.
SARs cost impact — Abhijeet Sakhare
AnsweredNo impact Q1. ~12 lakh SARs; ₹130-140 Cr value × 40-60% vesting = ~₹60 Cr spread over 4 years starting Q2.
Full-year cost-to-income target — Abhijeet Sakhare
AnsweredYes, 49-50% full-year target (vs 51.3% Q1). Q4 should show 49-49.5%.
Cost nature (fixed vs variable) — Abhijeet Sakhare
AnsweredPermanent in competitive industry. GBs/JBs create 24-30 month ramp cycles for new hires to rebuild books. Equilibrium well-measured; no dramatic change 2-3 years despite hiring cycles.
UHNI client base doubling distribution — Abhijeet Sakhare
Answered>₹250 Cr starting point: 70-80% advisory. ₹50-250 Cr: 50-50. ₹10-50 Cr: distribution-skewed. Advisory has 3x higher cross-platform usage and true engagement; retention spread by product lines offset by wallet expansion.
FCNR-B product strategy — Prakhar Sharma
AnsweredOpen architecture: working with 8-10 lenders and 8-10 bankers. Not banking as originator, but advisory. Clients accessing FCNR(B) via partnerships; 360 ONE adds advisory layer and optimization.
CEO continuity post-Bain exit — Prakhar Sharma
AnsweredLongevity as CEO independent of equity stake. Driven by passion, health (age 49), mental/emotional (85-100% invested) and financial (>90% invested). No horizon set; continuous basis review. No changes contemplated.
Guidance
ARR AUM growth 12-15% FY27
HighQ1 delivered 19% YoY; sustained momentum from onboarded teams and organic growth. Wealth +24.2%, AM +8.2%. Trajectory strong.
Total net flows ₹35-40k Cr (12-15% of ₹240k Cr opening AUM)
HighQ1 at ₹10.8k Cr pace; full-year trajectory 70:30 wealth-to-AMC split expected. Wealth flows ₹13.4k Cr vs ₹7k Cr Q4 confirm momentum.
TBR revenue ₹125-150 Cr/qtr recurring; up 10-15% annually
MediumQ1 at ₹208 Cr (exceptional). Shifting to lumpy-free model via co-investment structures. Equity brokerage ₹75 Cr/qtr stable base; upside from B&K integration and ECM ramp.
Cost-to-income improve 100-150 bps by Q4 FY27 (from 51.3% to 49-50%)
HighHNI expected break-even direct cost by end-FY27; ET Money run-rate ₹3-3.5 Cr loss trajectory clear. Operating leverage from wealth/AM business confirmed.
Stable UHNI cost-to-income 45-47% structurally (accounting for hiring)
HighPerpetual hiring offset by productivity cycles. Bridge to 47% from 50-51% via support functions (HNI/ET Money). No capex-driven margin expansion.
RM additions 30-40/year toward 350-400 target; UHNI will need 300-350 RMs for 9-10k families
HighHiring calibrated to 24-30 month productivity ramp. No explicit capex disclosed; talent investment primary.
Risks the call surfaced
Revenue recognition gap
High₹356 Cr variance between disclosed ₹870 Cr (ARR+TBR) and delivered ₹1,226 Cr revenue. Undisclosed revenue streams (carry, advisory fees, lending, other) inflating delivered vs operating revenue. Raises questions on sustainability and management transparency.
Retention pressure in listed equity
MediumListed equity business (8-9% of revenue) showing continued retention margin pressure. Pure listed AUM declining in favour of alternatives/advisory. If this segment shrinks below 5%, revenue mix shift could cap overall retention at 70-72 bps long-term.
FII flow volatility
MediumGlobal allocations to listed equity muted 6-9 months. One institutional mandate partial redemption ($550M→$175M) highlights concentration risk. If geopolitical uncertainty persists, institutional outflows could offset UHNI/HNI retail growth.
UBS collaboration unproven
MediumUBS partnership early-stage (Jan-Mar 2026 start). Target $500-600M AUM exchange conservative. Unit economics deferred; management non-committal on profitability timing. If collaboration underdelivers or integration costs overrun, medium-term growth assumptions at risk.
Cost-to-income target execution
Medium49-50% full-year cost-to-income target dependent on HNI reaching break-even direct cost by Q4 FY27 and ET Money run-rate loss of ₹3-3.5 Cr. If either business underperforms (slower customer onboarding, higher churn), combined savings may be ₹50-75 Cr vs expected ₹80-100 Cr, pushing year-end ratio to 50-51%.
Management
Score 8/10. Detailed and specific on numbers; handled Q&A well. But selectively disclosed revenue (₹870 Cr vs delivered ₹1,226 Cr) and understated PAT growth (14.8% vs 16.1%), raising transparency concerns. Non-committal on UBS unit economics (deferred to 6-month review). Strong track record on AUM growth guidance (beat 400-700 bps), cost-to-income trajectory (51.3% Q1, on path to 49-50%), and HNI/ET Money profitability milestones. One institutional outflow and FII headwinds partially offset by strong domestic flows. 19% YoY AUM growth and 24.2% wealth growth are solid.
1 · Q2 FY27
HNI migration of 4k sub-10-Cr clients; trail revenue acceleration
2 · Q4 FY27
HNI profitability; ET Money break-even; cost-to-income 49-50%
3 · Oct-Dec 2026
ECM team build-out; active mandate pitching begins
Medium-term: HNI, ET Money break-even path, and UBS upside intact but early-stage.
Wealth flows under watch as cost momentum builds
360 One Wam heads to earnings with ARR AUM on guidance, markets testing valuation and the margin roadmap.
What to expect
~₹1,200–1,250 Cr
Q1 FY26: ₹911 Cr; guidance targets sustained momentum in wealth and alternates
~₹300–340 Cr
On track for mid-teens PAT growth; OPM margin strength remains a structural feature
Trending lower
Management targets 100–150 bps reduction full-year; Q1 will show early progress as scale and leverage kick in
12–15% ARR AUM growth
Wealth business momentum sustained; HNI and ET Money approaching profitability; key watch for flow trajectory
A strong quarter would show revenue above ₹1,240 Cr (clearing 12%+ QoQ), ARR AUM growth within the guidance band with net flows positive and broad-based, and early evidence of cost leverage—particularly from the wealth and HNI franchises scaling toward profitability. A weak quarter would signal net flows deteriorating, AUM growth slowing below 12%, or cost-to-income traction stalling; any sign of margin compression or a cautious management tone on macro headwinds would weigh on sentiment.
On track?
360 One Wam remains on trajectory. The FY27 guidance of 12–15% ARR AUM growth and a 100–150 bps cost-to-income reduction by year-end is grounded in Q4 FY26 momentum (PAT +16.8% YoY, revenue +15.1%). FY26 as a whole delivered 20.7% PAT growth to ₹1,225 Cr and 18.6% revenue growth to ₹3,144 Cr—a solid base for Q1 to build on. The wealth business remains the growth engine; HNI and ET Money breaking even would unlock reinvestment and margin upside. Any miss on AUM growth or flow weakness would be the key watch; the Street is tracking this closely as validation of the medium-term thesis.
What the Street says
Since last quarter
Regulatory & corporate actions: 360 ONE Asset Management received SEBI nod in May for GIFT City operations—a strategic plank for offshore wealth and cross-border flows. The UBS wealth management partnership continues to mature, with management signaling meaningful cross-border flow potential over the medium term. Board approved an ESAR (Employee Stock Appreciation Rights) Scheme 2026, subject to shareholder approval—a routine capital allocation and talent-retention measure.
Ownership & insider moves: FII holding has eased from 65.52% (Q3 FY26) to 63.33% (Q4 FY26)—a 2.19pp quarter-on-quarter dip, consistent with broader market caution on valuations. SMALLCAP World Fund divested 2.04% in May, reducing its stake to 5.95%. Promoter Kush & Kyra Bhagat created encumbrance on 13.5L shares in April—a routine pledge, not a forced sale; promoter holding remains stable at ~6.24%. No insider distress signals; the pledges reflect liquidity management.
M&A & strategic: 360 ONE Alternates completed the acquisition of Quark Solar (April 2026), strengthening the alternative assets franchise. First interim dividend of ₹6 per share (April 2026) reflects continued capital return confidence.
What to watch on result day
1 · ARR AUM growth and net flows
Management guidance of 12–15% ARR AUM growth is the litmus test. Watch for both the headline AUM figure and the composition—wealth, HNI, alternates, advisory. Net flows absolute and as a % of average AUM will signal momentum in a rising-rate environment. Any slowdown below 12% would be a miss.
2 · Cost-to-income ratio and operating margin
The path to 100–150 bps improvement by Q4 FY27 starts with Q1 progress. Watch for early signs of leverage—particularly from scale in HNI and ET Money. OPM has held strong (63% in prior Q4); any material compression would be a red flag. Management commentary on cost discipline and headcount productivity will matter.
3 · HNI & ET Money path to profitability
Guidance promised these divisions would approach break-even by year-end. Q1 losses (if any) and the trajectory will be key. A narrowing of losses QoQ or early profitability would validate the business model; continued wide losses would raise questions on the roadmap.
4 · Cross-border flows and UBS partnership update
Management flagged meaningful cross-border flow potential from the UBS collaboration. Any quantitative update on this pipeline (flows in, traction with HNWIs on offshore strategies) would be material to the medium-term thesis and could re-rate the stock.
5 · Management guidance for FY27 and commentary on macro
Reconfirmation of full-year guidance (or any revision) will set the tone. Watch for commentary on market volatility, valuations, NPA concerns in credit, and any headwinds on fund flows. Tone will matter as much as numbers.
360 One Wam is priced for execution: modest upside is embedded in current valuations (~28–30x forward P/E), contingent on the company delivering the cost-margin roadmap while sustaining AUM growth. Q1 will show early validation of that thesis. The wealth business momentum and HNI/ET Money inflection are genuine structural tailwinds; the Street is aligned on this. The test is operationally tight—can management narrow the cost-to-income ratio early, and can net flows remain robust in a market that has rotated away from high valuations? The answer lies in the numbers Q1 will unveil, but the setup is constructive: flows are tracking, scale is kicking in, and the UBS partnership is adding to the addressable market.
Key watch items: AUM growth within 12–15%, net flows positive and broad-based, early cost-to-income traction (even 25–30 bps in Q1 would be a positive signal), and HNI/ET Money loss narrowing. Any of these would support the bull case; misses would invite scrutiny on execution risk and multiples.